CLRN1 | Clarin 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCG5 | ATP-binding cassette, sub-family G (WHITE), member 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCG8 | ATP-binding cassette, sub-family G (WHITE), member 8 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
AC106876.2 | Uncharacterized protein | | | | | | Group enriched |
ACE | Angiotensin I converting enzyme | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ACY1 | Aminoacylase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
AL162431.1 | Uncharacterized protein | | | | | | Group enriched |
ALDOB | Aldolase B, fructose-bisphosphate | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
ALPI | Alkaline phosphatase, intestinal | Enzymes Predicted secreted proteins
| | | | | Group enriched |
AMN | Amnion associated transmembrane protein | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
ANPEP | Alanyl (membrane) aminopeptidase | CD markers Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
AOC1 | Amine oxidase, copper containing 1 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
APOA1 | Apolipoprotein A-I | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOA4 | Apolipoprotein A-IV | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOB | Apolipoprotein B | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOBEC1 | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 | | | | | | Group enriched |
AQP10 | Aquaporin 10 | Predicted membrane proteins Transporters
| | | | | Group enriched |
ARL14 | ADP-ribosylation factor-like 14 | | | | | | Group enriched |
ASAH2 | N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
ASAH2C | N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2C | Enzymes
| | | | | Group enriched |
ATOH1 | Atonal homolog 1 (Drosophila) | Cancer-related genes Plasma proteins Transcription factors
| | | | | Group enriched |
BCL2L15 | BCL2-like 15 | | | | | | Group enriched |
BEST4 | Bestrophin 4 | Predicted membrane proteins
| | | | | Group enriched |
BTNL3 | Butyrophilin-like 3 | Predicted membrane proteins
| | | | | Group enriched |
BTNL8 | Butyrophilin-like 8 | Predicted membrane proteins
| | | | | Group enriched |
C11orf86 | Chromosome 11 open reading frame 86 | | | | | | Group enriched |
C17orf78 | Chromosome 17 open reading frame 78 | Predicted membrane proteins
| | | | | Group enriched |
C19orf69 | Chromosome 19 open reading frame 69 | | | | | | Group enriched |
C6orf58 | Chromosome 6 open reading frame 58 | Predicted secreted proteins
| | | | | Group enriched |
C8G | Complement component 8, gamma polypeptide | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
CAPN13 | Calpain 13 | Enzymes
| | | | | Group enriched |
CASP16 | Caspase 16, apoptosis-related cysteine peptidase (putative) | Enzymes
| | | | | Group enriched |
CASP5 | Caspase 5, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Plasma proteins
| | | | | Group enriched |
CCL25 | Chemokine (C-C motif) ligand 25 | Predicted secreted proteins
| | | | | Group enriched |
CDH17 | Cadherin 17, LI cadherin (liver-intestine) | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CDHR2 | Cadherin-related family member 2 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CDX1 | Caudal type homeobox 1 | Transcription factors
| | | | | Group enriched |
CDX2 | Caudal type homeobox 2 | Cancer-related genes Transcription factors
| | | | | Group enriched |
CEACAM18 | Carcinoembryonic antigen-related cell adhesion molecule 18 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CFTR | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
CHP2 | Calcineurin-like EF-hand protein 2 | Cancer-related genes
| | | | | Group enriched |
CHST5 | Carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 5 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CLCA1 | Chloride channel accessory 1 | Predicted secreted proteins
| | | | | Group enriched |
CLDN15 | Claudin 15 | Predicted membrane proteins Transporters
| | | | | Group enriched |
CLRN3 | Clarin 3 | Predicted membrane proteins Transporters
| | | | | Group enriched |
CPS1 | Carbamoyl-phosphate synthase 1, mitochondrial | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Group enriched |
CREB3L3 | CAMP responsive element binding protein 3-like 3 | Predicted membrane proteins Transcription factors
| | | | | Group enriched |
CTSE | Cathepsin E | Enzymes Predicted secreted proteins
| | | | | Group enriched |
CYP2D6 | Cytochrome P450, family 2, subfamily D, polypeptide 6 | Enzymes Predicted membrane proteins
| | | | | Group enriched |